News Posts

• Ainos Announces Pricing of $3.3 Million Public Offering, Uplisting to NASDAQ, and Reverse Stock Split

• Apexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company

• Brookline Capital Markets Hosts Biotech Symposium Today

• Brookline Capital Markets Announces Strategic Partnership Agreement with Stuart Frankel & Co.

• SCYNEXIS Announces Closing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants

• Scientific Industries Secures New Funding to Accelerate Growth of Its Bioprocessing Business

• Relativity Acquisition Corp. Announces Closing of $143.75 Million Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option

• Western Acquisition Ventures Corp. Prices $100 Million Initial Public Offering

• Larkspur Health Acquisition Corp. Prices $75 Million Initial Public Offering

• Ault Disruptive Technologies Corporation Prices $100 Million Initial Public Offering